484: SAKK 16/18: QA and interim safety of immune-modulatory RT in resectable stage III(N2) NSCLC. - Finazzi, Tobias; Holer, Lisa; Tang, Hongjian; Riesterer, Oliver; Allal, Abdelkarim; Elicin, Olgun; Glatzer, Markus; Durham, André; Martucci, Francesco; Adam, Lukas; Mosna-Firlejczyk, Katarzyna; Bettini, Adrienne; et al. (Radiotherapy & Oncology, 2024)